Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Irina Udalova on her successful Wellcome Trust Investigator Award entitled “Molecular control of pathogenic neutrophil responses in inflammation”.

Irina has been awarded £1.5 million over 5 years to research how neutrophil function in the tissue is guided by intrinsic molecular regulators and influenced by extrinsic protein and lipid signals produced by macrophages. Recent work has highlighted a number of factors that will be functionally validated and the hypothesis that neutrophil accumulation and activity in tissues during sterile inflammation is controlled by resident and effector macrophages will be examined. Understanding the control of pathogenic neutrophil responses and identification of key regulators will help to redefine these understudied cells in chronic inflammatory disorders such as such as rheumatoid arthritis, atherosclerosis, diabetes  amongst others and may lead to new treatments reducing the burden of human chronic inflammatory disease.

Speaking of the award, Professor Udalova stated “I am delighted to receive this award as the recognition of our unique expertise in neutrophil genomics, recently developed cutting edge technologies and established key strategic collaborations. I believe our work in this extremely interesting and completely under-studied area of research in neutrophil biology will lead to important and transforming discoveries”.

The grant will start on the 1st February 2018.

Similar stories

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.